AbTx
Dijon, France
◆ Total Raised
$2.0M
◆ Stage
seed
◆ Location
Dijon, France
◆ Founded
2024
◆ Team size
1-10
◆ About AbTx
French biotech company developing miniaturized antibody-drug conjugates for solid tumors using its patented Therano-Stick platform.
◆ What sets it apart
Therano-Stick enables miniaturized antibody fragment-drug conjugates that aim for deeper tumor penetration and better tolerability than conventional ADCs.
◆ Sectors
◆ Business
Modeltransactional
CustomerPharmaceutical and biotech partners, and ultimately patients with hard-to-treat solid tumors
◆ Notable
- Founded in 2024
- Raised seed funding
- Developed patented Therano-Stick platform
- Selected for oncology startup and partnering events in France
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does AbTx do?
French biotech company developing miniaturized antibody-drug conjugates for solid tumors using its patented Therano-Stick platform.
Where is AbTx based?
AbTx is based in Dijon, France, founded in 2024.
How much has AbTx raised?
AbTx has raised $2.0M in tracked funding and is currently at the seed stage.